APOE and Alzheimer disease: Further analyses indicated that the APOE-ε4ε4 haplotype carriers were less likely to participate in the MHQ and high genetic liability for Alzheimer’s disease lowered odds of participation in the FFQ, physical activity monitoring and the MHQ.